Literature DB >> 21775278

Long-term results and prognostic factors of patients with cervical carcinoma treated with concurrent chemoradiotherapy.

Ana Reig1, Ismael Membrive, Palmira Foro, Xavier Sanz, Núria Rodríguez, Joan Lozano, Martí Lacruz, Jaume Quera, Enric Fernández-Velilla, Manuel Algara.   

Abstract

AIMS AND
BACKGROUND: To evaluate the predictive factors of recurrence in cervical cancer treated with radical radiochemotherapy.
METHODS: A retrospective analysis of 56 women was performed. Response was assessed using the RECIST response. Overall survival and disease-free survival curves were estimated by the Kaplan-Meier method and the Cox proportional hazards model was used to analyse predictors of recurrence.
RESULTS: Local recurrence was documented in 16 patients and distant metastases in 15. The Kaplan-Meier survival probabilities were 95.1 ± 6.4% at 3 years and 80.4 ± 13.1% at 5 years and the Kaplan-Meier curve values for disease-free survival were 60.3 ± 14.3% at 3 years and 53.0 ± 15.7% at 5 years. Thirty-five patients were alive and 21 patients died, 19 from metastatic disease and 2 from other causes. Complete response after chemoradiation therapy, squamous cell carcinoma and tumour size ≤ 4 cm were significantly associated with outcome. In the Cox regression model, tumour size > 4 cm (hazard ratio 7.48; 95% CI 2.71-20.6; p < 0.001) and partial response (hazard ratio 7.09; 95% CI 2.82-17.8; p < 0.001) were predictive factors for disease-free survival and partial response (hazard ratio 3.7; 95% CI 1.3-10.1; p < 0.001) and non-squamous cell carcinoma (hazard ratio 3.5; 95% CI 1.2-9.7; p < 0.001) were predictive factors for overall survival.
CONCLUSIONS: Non-squamous histology and partial response were independent prognostic factors for overall survival and tumour size and partial response were independent prognostic variables for 5-year disease survival.

Entities:  

Mesh:

Year:  2011        PMID: 21775278     DOI: 10.1007/s12094-011-0688-8

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  26 in total

1.  Chemotherapy and radiotherapy for locally advanced cervical cancer.

Authors:  C Williams
Journal:  BMJ       Date:  1999-05-01

2.  Time to add chemotherapy to radiotherapy for cervical cancer.

Authors:  J Monaghan
Journal:  Lancet       Date:  1999-04-17       Impact factor: 79.321

3.  New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.

Authors:  P Therasse; S G Arbuck; E A Eisenhauer; J Wanders; R S Kaplan; L Rubinstein; J Verweij; M Van Glabbeke; A T van Oosterom; M C Christian; S G Gwyther
Journal:  J Natl Cancer Inst       Date:  2000-02-02       Impact factor: 13.506

Review 4.  Effects of different chemotherapy regimens on survival for advanced cervical cancer: systematic review and meta-analysis.

Authors:  Spyridon Tzioras; Nicholas Pavlidis; Evangelos Paraskevaidis; John P A Ioannidis
Journal:  Cancer Treat Rev       Date:  2006-11-16       Impact factor: 12.111

5.  Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix.

Authors:  R Pearcey; M Brundage; P Drouin; J Jeffrey; D Johnston; H Lukka; G MacLean; L Souhami; G Stuart; D Tu
Journal:  J Clin Oncol       Date:  2002-02-15       Impact factor: 44.544

6.  [Neoadjuvant radiochemotherapy and surgery of locally advanced cervical carcinoma: review of 22 patients treated at the Bordet Institute].

Authors:  D Noterman; C Philippson; D Hertens; I Veys; J-C Schobbens; J-M Nogaret
Journal:  J Gynecol Obstet Biol Reprod (Paris)       Date:  2006-02

Review 7.  Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix.

Authors:  J Green; J Kirwan; J Tierney; C Vale; P Symonds; L Fresco; C Williams; M Collingwood
Journal:  Cochrane Database Syst Rev       Date:  2005-07-20

8.  Cervical cancer state-of-the-clinical-science meeting on pretreatment evaluation and prognostic factors, September 27-28, 2007: proceedings and recommendations.

Authors:  Edward L Trimble
Journal:  Gynecol Oncol       Date:  2009-08       Impact factor: 5.482

9.  Analysis of multiple prognostic factors in patients with stage IB cervical cancer: age as a major determinant.

Authors:  M J Dattoli; H F Gretz; U Beller; I A Lerch; R I Demopoulos; E M Beckman; P R Fried
Journal:  Int J Radiat Oncol Biol Phys       Date:  1989-07       Impact factor: 7.038

10.  Carcinoma of the uterine cervix. I. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy.

Authors:  C A Perez; P W Grigsby; H Castro-Vita; M A Lockett
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-07-30       Impact factor: 7.038

View more
  4 in total

1.  Treatment of cervical cancer: the importance of a multidisciplinary team approach.

Authors:  J Alejandro Pérez Fidalgo; Ana Hernández Machancoses; Víctor Martín González; Andrés Cervantes
Journal:  Clin Transl Oncol       Date:  2011-07       Impact factor: 3.405

2.  Efficacy and Safety of Image-Guided Intensity-Modulated Radiation Therapy and Volumetric Modulated Arc Therapy Combined with Paclitaxel Liposomes and Cisplatin for Locally Advanced Stage IIB-IIIB Cervical Cancer: A Retrospective Study at a Single Center.

Authors:  Meihua Xie; Xiuxiu Ding; Aiyu Chen; Huiqin Xiao; Xiaoye Wang; Youhong Wang; Huan Zhang
Journal:  Med Sci Monit       Date:  2020-12-09

3.  The Prognostic Value of Tumor Size, Volume and Tumor Volume Reduction Rate During Concurrent Chemoradiotherapy in Patients With Cervical Cancer.

Authors:  Chang Sun; Shubin Wang; Wenjing Ye; RanLin Wang; Mingyu Tan; Hanyi Zhang; Jie Zhou; Minglun Li; Lichun Wei; Peng Xu; Guiquan Zhu; Jinyi Lang; Shun Lu
Journal:  Front Oncol       Date:  2022-07-14       Impact factor: 5.738

4.  Radical hysterectomy with adjuvant radiotherapy versus radical radiotherapy for FIGO stage IIB cervical cancer.

Authors:  Yanlan Chai; Tao Wang; Juan Wang; Yunyi Yang; Ying Gao; Jiyong Gao; Shangfeng Gao; Yueling Wang; Xi Zhou; Zi Liu
Journal:  BMC Cancer       Date:  2014-02-04       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.